Unlock Your Wealthier Future Today
We've been selecting winning stocks for 10 years. Get your investing life on the fast track now with our completely free, high-performing stock.
Which Is A Better ETF Investment Right Now: ARKK or SARK?
We take a look at two ETFs that provide an alternative to one another, but should investors be long or short disruptive innovation?
Feb. 3, 2022

Over the last few years, growth stocks have had stellar returns, with people rushing to buy businesses involved in industries such as electric vehicles, genomics, fintech, and more. While many such as Cathie Wood, believe in growth investing and the future potential in these industries, others believe that valuations have gotten lofty. After a turbulent start to 2022, should investors buy the ARK Innovation ETF (NYSEARCA: ARKK) or the Tuttle Capital Short Innovation ETF (NASDAQ: SARK)?

ARK Innovation ETF

The ARK Innovation ETF is ARK Invests flagship fund led by famed investor Cathie Wood. The fund revolves around companies making technologically enabled products and services that potentially change how the world works, and it calls this "disruptive innovation". 

The fund invests with a five-year time horizon and provides diversification across disruptive industries. It currently comprises 43 stocks, with Tesla the largest holding with a weighting of roughly 8%, followed by Teladoc, Zoom, Roku, and Coinbase

Despite the recent downturn, the ETF has returned an impressive 236% over the last five years, more than double that of the S&P 500. An investment in ARK Innovation will require patience but can potentially produce outsized returns over the long term. 

Many of its largest holdings are trading at high valuations and are unprofitable. Declines in larger holdings due to inflation fears, high-interest rates, and high valuations have weighed on the ETF's performance and may continue to do so for some time. 

Tuttle Capital Short Innovation ETF:

The Tuttle Capital Short Innovation ETF, SARK hereafter, was launched in November 2021. The ETF aims to achieve the inverse (-1X) of the return of the ARK Innovation ETF on a single day. 

The SARK ETF provides an alternative for investors who believe that high growth stocks valuations have risen too high and that the bull thesis for these disruptive industries such as fintech and genomics, among others, seems stretched. Since inception, this has paid off with a 23% return versus a negative return for many major indices and the ARK Innovation ETF over the same time period. 

Tuttle Capital CEO Matthew Tuttle stated that it focused on ARKK due to its holdings in "unprofitable, high-multiple technology". This ETF may be a useful tool to hedge against declines in growth stocks and major indices, particularly in volatile times such as 2022, where the tech-heavy Nasdaq and S&P 500 have both entered correction territory. 

The SARK ETF has an expense ratio of 0.75% due to it being an actively managed fund, but this also eats into returns. 

It also has a limited operating history, and although it has been successful since its inception, this does not mean it will continue to do so. Inverse ETFs are typically only held for one day and can lead to losses quickly if, in this case, the Ark Innovation ETF rises. 

So, which ETF is a better buy today?

Although the Tuttle Capital Short Innovation ETF can be used as a tool to provide short exposure, Cathie Wood's ARK Innovation ETF appears to remain an excellent long-term investment for those with a high-risk appetite.



The Home of Successful Investing.

© 2024 MyWallSt Ltd. All rights reserved.


Services

Content

Social

Company

Support

Resources


This website is operated by MyWallSt Ltd (“MyWallSt”). MyWallSt is a publisher and a technology platform, not a registered broker-dealer or registered investment adviser, and does not provide investment advice. All information provided by MyWallSt Limited is of a general nature for information and education purposes, and you should not construe any such information as investment advice. MyWallSt Limited does not take your specific needs, investment objectives or financial situation into consideration, and any investments mentioned may not be suitable for you. You should always carry out your own independent verification of facts and data before making any investment decisions, as we cannot guarantee the accuracy or completeness of any information we publish and any opinions that we publish may be wrong and may change at any time without notice. If you are unsure of any investment decision you should seek a professional financial advisor. MyWallSt Limited is not a registered investment adviser and we do not provide regulated investment advice or recommendations. MyWallSt Limited is not regulated by the Central Bank of Ireland. MyWallSt Limited may provide hyperlinks to web sites operated by third parties. Your use of third party web sites and content, including without limitation, your use of any information, data, advertising, products, or other materials on or available through such web sites, is at your own risk and is subject to the third parties' terms of use.